BIOMAT Database Logo BIOMAT Database Logo

L-DOPA suppression of thyrotropin-releasing hormone response in man. 1972

S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013972 Thyrotropin A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity. Thyroid-Stimulating Hormone,TSH (Thyroid Stimulating Hormone),Thyreotropin,Thyrotrophin,Hormone, Thyroid-Stimulating,Thyroid Stimulating Hormone

Related Publications

S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
August 1975, The Journal of clinical endocrinology and metabolism,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Response to synthetic thyrotropin-releasing hormone in man.
October 1970, The Journal of clinical endocrinology and metabolism,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
March 2004, Progress in neuro-psychopharmacology & biological psychiatry,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Plasma growth hormone and prolactin response to thyrotropin releasing hormone, L-dopa and luteinizing hormone-releasing hormone in alcoholic patients with liver cirrhosis.
September 1980, Il Farmaco; edizione pratica,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Response to thyrotropin releasing hormone (TRH) in normal man.
February 1972, The Journal of clinical endocrinology and metabolism,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus.
January 1992, Endokrynologia Polska,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man.
September 1981, The Journal of clinical endocrinology and metabolism,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Inhibition by L-triiodothyronine and dexamethasone of TSH response to thyrotropin releasing hormone in man.
January 1972, Annales d'endocrinologie,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Individual variations in the effects of flurazepam, clorazepate, L-dopa and thyrotropin-releasing hormone on REM sleep in man.
January 1979, Psychopharmacology,
S W Spaulding, and G N Burrow, and R Donabedian, and M van Woert
Response to orally administered synthetic thyrotropin-releasing hormone in man.
November 1972, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!